Accelerate diagnostics, inc. (AXDX)
CashFlow / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Oct'12Sep'12Jun'12Mar'12Dec'11Oct'11Jul'11Apr'11Jan'11Oct'10
Cash flows from operating activities:
Net loss

-21,309

-21,335

-20,434

-20,815

-21,721

-22,191

-22,098

-23,225

-20,812

-16,295

-17,076

-16,457

-14,200

-16,135

-17,299

-17,866

-15,074

-13,163

-11,186

-12,252

-8,897

-8,765

-8,814

-8,152

-5,202

-5,160

-3,796

-3,777

-2,549

436

-1,665

-3,836

-1,123

-299

-156

-430

-295

-123

-26

67

Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization

755

740

626

610

626

812

667

538

544

601

550

540

505

606

598

605

542

588

465

403

326

281

251

151

134

95

84

71

36

4

1

0

0

0

0

0

0

0

0

0

Amortization of intangible assets

-

-

-

-

-

-

-

-

-

-

3

3

3

-

3

2

3

2

3

3

2

15

18

19

19

19

20

19

19

27

25

10

64

64

-0

64

63

63

63

63

Amortization of investment discount

4

27

80

140

180

208

267

165

-19

-28

-79

-98

-121

-123

-128

-86

-37

-41

-48

-52

-47

-498

105

66

58

-76

0

0

0

-

-

-

-

-

-

-

-

-

-

-

Equity-based compensation

4,199

3,209

3,131

2,881

3,397

1,946

3,465

3,409

5,602

2,963

3,520

4,235

3,215

2,184

2,670

2,235

1,686

2,393

1,810

2,528

1,657

2,290

2,403

3,171

1,760

1,216

1,007

1,168

437

98

168

434

38

36

0

272

71

6

3

8

Provision for bad debt expense

8

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Amortization of debt discount and issuance costs

2,674

-

2,527

2,456

2,387

-

2,256

2,115

158

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Unrealized loss on equity investments

-8

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Realized gain on sale of investments

-3

-

-

-

2

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Loss on disposal of property and equipment

-432

-

-170

-78

-329

-

-274

-255

-11

-

2

-5

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Unrealized gain on investments

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

10

-10

-

-

-

-4

4

22

-5

-17

-13

Realized gain on sale of investments, interest and dividends reinvested

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1

-1

-

-

-

0

0

-

-

-

-

Other expense, impairment loss

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

333

-

-

-

-

0

-

-

-

-

(Increase) decrease in assets:
Accounts receivable

9

580

731

-39

90

420

-383

758

-881

835

429

126

522

-125

-10

92

0

-665

599

51

14

119

-49

0

-16

-1,397

712

-25

-29

-610

-2

597

-2

-2

167

-165

430

-13

243

-248

Inventory

1,735

369

1,069

650

1,567

-983

872

2,417

1,917

680

1,542

1,382

4,155

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-0

10

-

-

0

0

0

0

2

0

-0

Prepaid expense and other

1,030

433

-269

-453

1,041

38

-485

-292

989

67

-232

167

457

-596

-253

-790

518

599

-33

571

104

713

-61

305

-791

213

6

-29

-76

-24

-1

26

4

-0

-17

9

11

5

-26

8

Other current assets

-

-

-

-

-

-

-

-

-

-

-36

33

280

-

-1,130

8

1,212

12

0

-647

647

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Increase (decrease) in liabilities:
Accounts payable

968

200

312

-675

1,151

-224

-730

-495

701

705

-169

252

276

-1,345

497

-888

494

658

-200

-295

166

808

32

371

125

498

-315

292

-270

149

20

86

-39

18

19

21

-59

19

11

32

Accrued liabilities, and other

-1,475

788

-1,005

680

-1,790

1,444

-679

-72

733

-184

388

396

-4

949

-505

269

906

-573

743

156

501

-45

-72

-47

244

193

-591

-124

166

-667

28

794

6

0

-4

11

-13

10

-6

10

Accrued interest

-1,071

1,071

-1,071

1,071

-1,071

1,071

-914

1,105

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred revenue and income

-85

21

-5

-36

74

14

17

68

-1,003

-10

3

14

29

-9

1

-15

-69

114

0

-14

0

190

-2

-16

-4

248

38

503

-8

3

-2

-10

-3

-8

-0

95

9

-16

0

-4

Deferred compensation

74

-9

-7

-11

-7

27

0

1

4

21

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

71

0

-71

-20

-17

-89

16

-1

26

37

34

Net cash used in operating activities

-17,597

-13,865

-17,367

-14,057

-19,505

-14,326

-18,013

-19,349

-16,068

-13,248

-14,407

-12,622

-15,469

-12,801

-12,520

-14,882

-13,205

-9,886

-8,883

-9,394

-6,963

-4,791

-6,189

-4,132

-3,673

-2,747

-2,826

-1,902

-2,274

-2,165

-1,094

29

-1,073

-208

-85

-99

237

-26

279

-42

Cash flows from investing activities:
Purchases of equipment

438

182

72

39

37

156

140

-592

1,294

911

412

1,414

229

108

217

403

1,681

1,062

434

962

1,198

3,290

-628

-305

-424

68

193

222

675

-203

73

45

46

22

-33

14

28

67

-3

-17

Purchase of marketable securities

21,582

-

-

-

12,826

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Purchase investments

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-1

-

-

-

-1

Contribution to deferred compensation trust

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-

0

91

-75

0

0

-75

0

Purchase of marketable securities

-

-

-

-

-

4,922

24,362

81,916

9,356

13,910

29,081

34,780

4,562

490

10,051

26,816

36,718

0

4,401

3,514

4,503

14,271

-2,535

-3,565

-514

22,963

-10,949

0

0

-

-

-

-

-

-

-

-

-

-

-

Proceeds from sales of marketable securities

0

1,100

0

4,400

9,000

0

0

0

3,000

2,000

3,000

6,522

0

1,000

7,716

500

500

0

0

34

107

615

125

121

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Maturities of marketable securities

16,664

9,945

24,475

25,785

28,662

23,920

36,224

18,147

20,125

18,000

11,600

9,604

8,845

2,245

5,575

5,980

3,400

1,951

3,500

1,452

6,355

1,350

2,007

2,000

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net cash (used in) provided by investing activities

-5,356

-18,653

21,294

25,371

24,799

18,842

11,722

-63,177

12,475

5,179

-14,893

-20,068

4,054

2,647

3,023

-20,739

-34,499

889

-1,335

-2,990

761

346

-1,031

-1,749

-938

-1,133

-11,142

-222

-675

-112

-73

-45

-46

-22

88

-91

-28

-26

-77

-18

Cash flows from financing activities:
Common stock issuance cost

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

814

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from exercise of options and warrants

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

1

19,911

-20,137

20,137

-

-

-

-

-

-

-

-

-

-

-

Rights offering costs incurred

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-6

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

Payments on capital lease obligations

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

13

37

37

37

36

178

-36

-35

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from issuance of common stock

111

-

1,112

112

139

-

171

142

134

-

-113

83,665

189

-

80

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from exercise of options

1,318

-3,421

510

692

3,677

-3,127

953

1,645

1,112

79,259

1,144

1,574

1,844

633

769

67

28

263

215

261

66

193

0

0

730

455

337

20,177

0

100

100

0

0

0

-128

128

-

-

-

-

Proceeds from issuance of convertible note

-

-

-

-

-

0

1

21,499

150,000

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Prepayment of forward stock repurchase transaction

-

-

-

-

-

0

0

0

45,069

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Payment of debt issuance costs

-

-

-

-

-

0

1

661

4,330

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net cash provided by financing activities

1,429

581

1,622

804

3,816

175

1,124

22,625

101,847

2,124

1,031

85,239

2,033

779

724

1,058

-799

104,391

178

224

30

157

-141

44,951

724

456

20,248

40

20,137

100

100

0

14,548

0

-128

128

-

-

-

-

Effect of exchange rate on cash

-3

13

-80

42

-61

-53

-21

-136

80

27

91

143

55

-112

-15

49

-49

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

(Decrease) increase in cash and cash equivalents

-21,527

-31,924

5,469

12,160

9,049

4,638

-5,188

-60,037

98,334

-5,918

-28,178

52,692

-9,327

-9,487

-8,788

-34,514

-48,552

95,394

-10,040

-12,160

-6,172

-4,288

-7,361

39,070

-3,887

-3,424

6,280

-2,084

17,188

-2,178

-1,067

-15

13,428

-230

2

-190

403

-53

202

-60

Non-cash investing activities:
Non-cash investing activities:
Transfer of instruments from inventory to property and equipment

1,282

136

1,510

946

769

706

2,865

1,196

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Supplemental cash flow information:
Interest paid

2,144

0

2,144

0

2,144

0

2,001

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Income taxes paid, net of refunds

26

-

-

-

2

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Income taxes paid, net of refunds

-

-

-

-

-

216

396

39

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-